SCHEMBL331540

SCHEMBL331540

CCNCCCCCCNCC

nearest known ligand 0.80

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.80
CYP1A2 P05177 1/20 0.80
MEN1 O00255 1/20 0.73
GLA P06280 1/20 0.73
KMT2A Q03164 1/20 0.73
TSHR P16473 2/20 0.69
KDM1A O60341 5/20 0.68
ALDH1A1 P00352 1/20 0.53
SAT1 P21673 3/20 0.50
TP53 P04637 1/20 0.50
HRH4 Q9H3N8 2/20 0.43
HRH3 Q9Y5N1 2/20 0.43
EPHX1 P07099 2/20 0.41
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41
ADH7 P40394 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089751 1.00 CYP2C19 (0.80) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL13893419 1.00 CYP2C19 (0.80) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL19620508 1.00 CYP2C19 (0.80) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL332342 1.00 CYP2C19 (0.80) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL331498 1.00 CYP2C19 (0.80) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL7097560 0.96 CYP2C19 (0.87) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL7091884 0.96 CYP2C19 (0.87) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL7096788 0.96 CYP2C19 (0.87) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL7513770 0.96 CYP2C19 (0.87) CYP2C19CYP1A2MEN1GLAKMT2A
SCHEMBL7092406 0.96 CYP2C19 (0.87) CYP2C19CYP1A2MEN1GLAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 632 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260090364-A1 METHOD OF MANUFACTURING SACRIFICIAL LAYER AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-03-26 US claimed
CN-114716640-A Aqueous polyurethane-polyurea dispersion and preparation method thereof 深圳飞扬兴业科技有限公司 2022-07-08 CN claimed
US-10067266-B2 Method of producing resin for thiourethane-based optical material using general-purpose polyisocyanate compound, resin composition for thiourethane-based optical material and thiourethane-based optical material including resin produced by the method KOC SOLUTION CO., LTD. (KR) 2018-09-04 US claimed
EP-2682430-B1 METHOD FOR MANUFACTURING RESIN FOR THIOURETHANE-BASED OPTICAL MATERIAL USING UNIVERSAL POLYISOCYANATE COMPOUND, RESIN COMPOSITION, AND OPTICAL MATERIAL MANUFACTURED THEREBY KOC SOLUTION CO LTD (KR) 2015-10-21 EP claimed
US-20140039145-A1 METHOD OF PRODUCING RESIN FOR THIOURETHANE-BASED OPTICAL MATERIAL USING GENERAL-PURPOSE POLYISOCYANATE COMPOUND, RESIN COMPOSITION FOR THIOURETHANE-BASED OPTICAL MATERIAL AND THIOURETHANE-BASED OPTICAL MATERIAL INCLUDING RESIN PRODUCED BY THE METHOD KOC SOLUTION CO LTD (KR) 2014-02-06 US claimed
EP-2682430-A2 METHOD FOR MANUFACTURING RESIN FOR THIOURETHANE-BASED OPTICAL MATERIAL USING UNIVERSAL POLYISOCYANATE COMPOUND, RESIN COMPOSITION, AND OPTICAL MATERIAL MANUFACTURED THEREBY Koc Solution Co.,LTD. (KR) 2014-01-08 EP claimed
US-7067592-B2 Thermoplastic elastomer composition THE YOKOHAMA RUBBER CO., LTD. (JP) 2006-06-27 US claimed
US-4075174-A BIS-SECONDARY DIAMINES GENERAL ELECTRIC COMPANY (US) 1978-02-21 US claimed
EP-4332140-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED PRODUCT, AND METHOD OF PRODUCING OPTICAL MATERIAL MITSUI CHEMICALS INC (JP) 2026-05-27 EP disclosed
EP-4282901-B1 PHOSPHAZENE BOND-CONTAINING POLYMER NIPPON CATALYTIC CHEM IND (JP) 2026-05-20 EP disclosed
WO-2026099070-A2 BLENDS OF THERMOPLASTIC POLYMERS WITH COVALENT ADAPTABLE NETWORKS COVESTRO DEUTSCHLAND AG (DE) 2026-05-15 WO disclosed
EP-4741436-A1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED ARTICLE, AND METHOD FOR PRODUCING OPTICAL MATERIAL Mitsui Chemicals, Inc. (JP) 2026-05-13 EP disclosed
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof ADEKA CORPORATION (JP) 2026-05-12 US disclosed
US-20260125584-A1 TWO-COMPONENT EPOXY ADHESIVE FOR LIQUIFIED NATURAL GAS CONTAINERS SIKA TECHNOLOGY AG (CH) 2026-05-07 US disclosed
US-4057518-A Process for the manufacture of heat resistant multicellular materials RHONE-POULENC INDUSTRIES (FR) 1977-11-08 US disclosed
US-4045229-A 1-AMINO-4-CYANO-1,3-BUTADIENE COMPOUNDS EASTMAN KODAK COMPANY (US) 1977-08-30 US disclosed
US-4022833-A ANTIBACTERIAL AGENTS STERLING DRUG INC. (US) 1977-05-10 US disclosed
US-4018748-A FOR FIBERS AND FILMS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-04-19 US disclosed
US-4013600-A STORAGE STABILITY RHONE-POULENC INDUSTRIES (FR) 1977-03-22 US disclosed
US-4010220-A AMINO COMPOUND, POLYURETHANE ELASTOMER RHONE-POULENC INDUSTRIES (FR) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090364-A1 METHOD OF MANUFACTURING SACRIFICIAL LAYER AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE BY USING THE SAME PRDM9, PRDM7, SNRK CYP2C19 2174/4885CYP1A2 2527/4885MEN1 1521/4885
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof SORD, SUCLA2, SUCLG1 CYP2C19 4010/4885CYP1A2 2298/4885MEN1 2208/4885
US-20260125584-A1 TWO-COMPONENT EPOXY ADHESIVE FOR LIQUIFIED NATURAL GAS CONTAINERS PTGER2, SETDB1, ITGA2 CYP2C19 4114/4885CYP1A2 858/4885MEN1 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.